Intelliseq is a Kraków-based bioinformatics company that automates the analysis and interpretation of variants in the human genome to support genetic diagnostics. Founded in 2014 by a team of scientists, it turns complex DNA sequencing data into clear, actionable clinical insights. Its flagship platform, iFlow, lets laboratories build modular analysis workflows that scale with diagnostic demand and produce complete reports for doctors and patients. The platform covers everything from a single gene to the whole genome, with ready-made tools for somatic cancer, hereditary diseases, pharmacogenomics and polygenic risk scores. Intelliseq works with international partners such as DNAnexus, whose Precision Health Data Cloud now includes its interpretation and reporting tools, and Oxford Gene Technology. The company already generates revenue in the US, its main expansion market. In 2025 it raised €4.5 million in a round led by Vinci HiTech, with Unfold.vc and private investors including Tadeusz Wesołowski.

‍